Fusion of the platelet-derived growth factor receptor beta to a novel gene CEV14 in acute myelogenous leukemia after clonal evolution.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Blood

• Publication date

  1997-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V90.11.4271.4271_4271_4277PMID 9373237
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chromosomal Translocation t ( l 5 ; 17 ) in Human Acute Promyelocytic Leukemia Fuses RARa with a Novel Putative Transcription Factor , PML

  2003cited by this paper
• The TEL/platelet-derived growth factor β receptor (PDGFβR) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGFβR kinase-dependent signaling pathways

  1996cited by this paper
• Is t(6;14) a non-random translocation in childhood acute mixed lineage leukemia?

  1996cited by this paper
• The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways.

  1996cited by this paper
• The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene.

  1996cited by this paper
• TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12)(q33;p13) translocation or its variant t(10;12)(q24;p13).

  1995cited by this paper
• The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion.

  1995cited by this paper
• Translocation (12;22) (p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11.

  1995cited by this paper
• Report of two cases

  1995cited by this paper
• Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor.

  1995cited by this paper
• Acute myeloblastic leukemia (M2) with translocation (7;11) followed by marked eosinophilia and additional abnormalities of chromosome 5.

  1995cited by this paper
• The novel activation of ABL by fusion to an ets-related gene, TEL.

  1995cited by this paper
• Establishment and characterization of an immature human megakaryoblastic cell line, MEG-A2.

  1995cited by this paper
• Generation of the AML1‐EVI‐1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia.

  1994cited by this paper
• Chromosomal translocations in human cancer

  1994cited by this paper
• Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation.

  1994cited by this paper
• A case of myelodysplasia with eosinophilia having a translocation t(5;12)(q31;q13) restricted to myeloid cells but not involving eosinophils

  1994cited by this paper
• Platelet-derived growth factor receptor mediates activation of ras through different signaling pathways in different cell types

  1993cited by this paper
• t(5;12)(q31;p12). A clinical entity with features of both myeloid leukemia and chronic myelomonocytic leukemia.

  1993cited by this paper
• Conservation of transcriptional activation functions of the NF-kappa B p50 and p65 subunits in mammalian cells and Saccharomyces cerevisiae

  1993cited by this paper
• The cytogenetic scenario of chronic myeloid leukemia.

  1993cited by this paper
• Phospholipase C-γ1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal

  1993cited by this paper
• Unexpected heterogeneity of PML/RAR alpha fused mRNA detected by nested polymerase chain reaction in acute promyelocytic leukemia.

  1993cited by this paper
• Rapid amplification of complementary DNA ends for generation of full-length complementary DNAs: thermal RACE.

  1993cited by this paper
• Acute myelomonocytic leukemia with inv(16)(p13q22) complicating Philadelphia chromosome positive chronic myeloid leukemia.

  1992cited by this paper
• Ph-positive chronic myeloid leukemia with t(8;21)(q22;q22) in blastic crisis.

  1992cited by this paper
• Inversion of chromosome 16 with the Philadelphia chromosome in acute myelomonocytic leukemia with eosinophilia. Report of two cases.

  1992cited by this paper
• A case of basophilic leukemia bearing simultaneous translocations t(8;21) and t(9;22).

  1991cited by this paper
• Atypical chronic myelomonocytic leukemia with eosinophilia and translocation (5;12). A new association.

  1991cited by this paper
• [A new association].

  1990cited by this paper
• Activation of the interleukin-3 gene by chromosome translocation in acute lymphocytic leukemia with eosinophilia.

  1990cited by this paper
• Activation of the interleukin-3 gene by chromosome translocation in acute lymphocytic leukemia with eosinophilia [see comments]

  1990cited by this paper
• Secondary acute promyelocytic leukemia with t(8;21) and t(9;22) at onset and loss of the Philadelphia chromosome at relapse.

  1990cited by this paper
• 14q32 translocations are associated with mixed-lineage expression in childhood acute leukemia.

  1990cited by this paper
• CD10-(CALLA)-Positive Lymphocytes in Myeloma: Evidence that they are a Malignant Precursor Population and are of Germinal Centre Origin.

  1989cited by this paper
• The t(5;14) chromosomal translocation in a case of acute lymphocytic leukemia joins the interleukin-3 gene to the immunoglobulin heavy chain gene.

  1989cited by this paper
• Dimerization of B-type platelet-derived growth factor receptors occurs after ligand binding and is closely associated with receptor kinase activation.

  1989cited by this paper
• Two karyotypically independent leukemic clones with the t(8;21) and 11q23 translocation in acute myeloblastic leukemia at relapse.

  1989cited by this paper
• Acute myelogenous leukemia (FAB M1) associated with t(5;16) and eosinophilia. Report of an additional case.

  1989cited by this paper
• Two karyotypically independent leukemic clones with the t(8;21) and 11q23 translocation in acute myeloblastic leukemia at relapse [published erratum appears in Blood 1989 Aug 15;74(3):1180]

  1989cited by this paper
• A Laboratory manual

  1989cited by this paper
• Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor: evidence for more than one receptor class.

  1988cited by this paper
• The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins.

  1988cited by this paper
• A myeloproliferative disease in two infants associated with eosinophilia and chromosome t(1;5) translocation

  1987cited by this paper
• Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18.

  1985cited by this paper
• Chromosome 16q, eosinophilia, and leukemia.

  1985cited by this paper
• Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation.

  1984cited by this paper
• Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

  1979cited by this paper

• Analysis of CD74 Occurrence in Oncogenic Fusion Proteins

  2023cites this paper
• A TRIP11:: FLT3 gene fusion in a patient with myeloid/lymphoid neoplasm with eosinophilia and tyrosine kinase gene fusions: a case report and review of the literature

  2023cites this paper
• Myeloid/lymphoid neoplasms with eosinophilia and FLT3 rearrangement.

  2020cites this paper
• Myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2: Overview 2019

  2020cites this paper
• Targeting ELTD1, an angiogenesis marker for glioblastoma (GBM), also affects VEGFR2: molecular-targeted MRI assessment.

  2019cites this paper
• Novel PDGFRB rearrangement in multifocal infantile myofibromatosis is tumorigenic and sensitive to imatinib

  2019cites this paper
• Cloning and characterization of a novel druggable fusion kinase in acute myeloid leukemia

  2019cites this paper
• Myeloid and Lymphoid Neoplasms with Eosinophilia and Abnormalities of PDGFRA , PDGFRB , FGFR1, or t(8;9)(p22;p24.1); PCM1-JAK2

  2018cites this paper
• PDGFRβ-Rearranged Myeloid Neoplasm with Marked Eosinophilia in a 37-Year-Old Man; And a Literature Review

  2017cites this paper
• A novel TRIP11-FLT3 fusion in a patient with a myeloid/lymphoid neoplasm with eosinophilia.

  2017cites this paper
• Platelet-derived growth factor receptors (PDGFRs) fusion genes involvement in hematological malignancies.

  2017cites this paper
• Fusion of platelet-derived growth factor receptor β to CEV14 gene in chronic myelomonocytic leukemia: A case report and review of the literature.

  2016cites this paper
• ETV6‐LPXN fusion transcript generated by t(11;12)(q12.1;p13) in a patient with relapsing acute myeloid leukemia with NUP98‐HOXA9

  2016cites this paper
• Chronic Myeloproliferative Neoplasms

  2015cites this paper
• The plasma proteome and outcome in patients with heart failure

  2015cites this paper
• Mutations in tyrosine kinase and tyrosine phosphatase and their relevance to the target therapy in hematologic malignancies.

  2015cites this paper
• Fusion of PDGFRB to MPRIP, CPSF6, and GOLGB1 in three patients with eosinophilia‐associated myeloproliferative neoplasms

  2015cites this paper
• Identification of novel genetic alterations in pediatric cytogenetically normal acute myeloid leukemia by next-generation sequencing

  2015cites this paper
• TRIP11-PDGFRB fusion in a patient with a therapy-related myeloid neoplasm with t(5;14)(q33;q32) after treatment for acute promyelocytic leukemia

  2014influential citation
• Human height genes and cancer.

  2013cites this paper
• Myeloid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, and FGFR1: a review

  2013cites this paper
• hematologic malignancies After chronic myelogenous leukemia: tyrosine kinase inhibitors in other

  2013cites this paper
• FuseFISH: robust detection of transcribed gene fusions in single cells.

  2013cites this paper
• The aryl hydrocarbon receptor nuclear translocator (ARNT) family of proteins: transcriptional modifiers with multi-functional protein interfaces.

  2013cites this paper
• Chronic Myeloid Leukaemias

  2013cites this paper
• Centrosomal targeting of tyrosine kinase activity does not enhance oncogenicity in chronic myeloproliferative disorders

  2012cites this paper
• Building the Cell's Antenna: Protein Targeting to the Ciliary Membrane: A Dissertation

  2012cites this paper
• Protein-protein interactions mediating hypoxia-inducible factor 1 complex function

  2012cites this paper
• Genetic aberrations in patients with leukaemia and their impact on prognosis

  2012cites this paper
• disorders Imatinib targets other than bcr/abl and their clinical relevance in myeloid

  2011cites this paper
• Eosinophilic Disorders: Differential Diagnosis and Management

  2011cites this paper
• PDGFRB (platelet-derived growth factor receptor, beta polypeptide)

  2011cites this paper
• Molecular alterations underlying eosinophilic and mast cell malignancies.

  2011cites this paper
• Abnormalities affecting tyrosine kinase signalling in atypical myeloproliferative disorders

  2009cites this paper
• Molecular diagnosis of myeloproliferative neoplasms

  2009cites this paper
• Chronic myelomonocytic leukemia.

  2008cites this paper
• Molecular drug targets in myeloproliferative neoplasms: mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1

  2008cites this paper
• Chronic eosinophilic leukemia/hypereosinophilic syndrome.

  2008cites this paper
• Five years since the discovery of FIP1L1–PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias

  2008cites this paper
• The Golgin GMAP210/TRIP11 Anchors IFT20 to the Golgi Complex

  2008cites this paper
• Nuclear receptor coregulators and human disease.

  2008cites this paper
• Roles for deregulated receptor tyrosine kinases and their downstream signaling molecules in hematologic malignancies

  2008cites this paper
• Fusion of PRKG2 and SPTBN1 to the platelet-derived growth factor receptor beta gene (PDGFRB) in imatinib-responsive atypical myeloproliferative disorders.

  2008cites this paper
• BCR-ABL-negative atypical chronic myeloproliferative disorders

  2008cites this paper
• Rare Hematological Malignancies

  2008cites this paper
• Extramedullary molecular evidence of the 5'KIAA1509/3'PDGFRB fusion gene in chronic eosinophilic leukemia.

  2008cites this paper
• Current Treatment Options: Impact of Cytogenetics on the Course of Myelodysplasia

  2007cites this paper
• The diagnostic interface between histology and molecular tests in myeloproliferative disorders

  2007cites this paper
• BCR-ABL-negative chronic myeloid leukemia

  2007cites this paper
• Role of Imatinib-Sensitive Tyrosine Kinases in the Pathogenesis of Chronic Myeloproliferative Disorders

  2007cites this paper
• Molecular mechanisms of signal transduction: epidermal growth factor receptor family, vascular endothelial growth factor family, Kit, platelet-derived growth factor receptor, Ras.

  2007cites this paper
• LRP16 is fused to RUNX1 in monocytic leukemia cell line with t(11;21)(q13;q22)

  2007cites this paper
• A multicenter analysis of the FIP1L1-αPDGFR fusion gene in Japanese idiopathic hypereosinophilic syndrome: an aberrant splicing skipping the αPDGFR exon 12

  2007cites this paper
• Characterization of three new imatinib-responsive fusion genes in chronic myeloproliferative disorders generated by disruption of the platelet-derived growth factor receptor beta gene.

  2007cites this paper
• Hypereosinophilic Syndrome, Chronic Eosinophilic Leukemia, and Mast Cell Disease

  2007cites this paper
• Tyrosine kinases as therapeutic targets in BCR-ABL negative chronic myeloproliferative disorders.

  2007cites this paper
• A multicenter analysis of the FIP1L1-alphaPDGFR fusion gene in Japanese idiopathic hypereosinophilic syndrome: an aberrant splicing skipping the alphaPDGFR exon 12.

  2007cites this paper
• Oncogenic fusion tyrosine kinases as molecular targets for anti-cancer therapy.

  2007cites this paper
• Oncogenes in Myeloproliferative Disorders

  2007cites this paper
• Clonal Evolution Is Associated With Blast Crisis

  2006cites this paper
• Signal transduction therapy in haematological malignancies: identification and targeting of tyrosine kinases.

  2006cites this paper
• Eosinophilia: secondary, clonal and idiopathic

  2006cites this paper
• Atypical myeloproliferative disorders: diagnosis and management.

  2006cites this paper
• Acute Myeloid Leukemias

  2006cites this paper
• Chronic myeloproliferative diseases with the t(5;12)(q33;p13): clonal evolution is associated with blast crisis.

  2006cites this paper
• Classification of chronic myeloid disorders: from Dameshek towards a semi-molecular system.

  2006cites this paper
• Eosinophilic disorders: molecular pathogenesis, new classification, and modern therapy.

  2006cites this paper
• Molecular Genetic Abnormalities in Acute and Chronic Leukemias

  2006cites this paper
• Cytogenetic Diagnosis of Myelodysplastic Syndromes

  2006cites this paper
• Developing target therapy against oncogenic tyrosine kinase in myeloid maliganacies.

  2006cites this paper
• Proteomics approaches to elucidate oncogenic tyrosine kinase signaling in myeloid malignancies.

  2006cites this paper
• The investigation of mutation and single nucleotide polymorphism of receptor tyrosine kinases and downstream scaffold molecules in acute myeloid leukemia

  2006cites this paper
• Investigations of FLT3 internal tandem duplications in patients with acute myeloid leukaemia

  2006cites this paper
• Can molecular profiling of cytogenetic subgroups draw a roadmap for individualizing therapy in myelodysplastic syndromes?

  2006cites this paper
• Transient response to imatinib in a chronic eosinophilic leukemia associated with ins(9;4)(q33;q12q25) and a CDK5RAP2‐PDGFRA fusion gene

  2006influential citation
• Chronic myeloproliferative disorders: a tyrosine kinase tale

  2006cites this paper
• KIAA1509 is a novel PDGFRB fusion partner in imatinib-responsive myeloproliferative disease associated with a t(5;14)(q33;q32)

  2005cites this paper
• Kinases as drug discovery targets in hematologic malignancies.

  2005cites this paper
• Diagnosis of an early precursor-B-ALL presenting with hypereosinophilia using FISH on immunomagnetically selected CD19+ cells.

  2005cites this paper
• Myeloproliferative disorders: the centrosome connection

  2005cites this paper
• The JAK2V617F tyrosine kinase mutation in myeloproliferative disorders: status report and immediate implications for disease classification and diagnosis.

  2005cites this paper
• After chronic myelogenous leukemia: tyrosine kinase inhibitors in other hematologic malignancies.

  2005cites this paper
• Modern Diagnosis and Treatment of Primary Eosinophilia

  2005cites this paper
• Oncogenic tyrosine kinase of malignant hemopathy targets the centrosome.

  2005cites this paper
• Myelodysplastic Syndromes: Cytogenetic abnormalities in myelodysplastic syndromes

  2005cites this paper
• Golgi tethering factors.

  2005cites this paper
• Molecular Classification and Pathogenesis of Eosinophilic Disorders: 2005 Update

  2005cites this paper
• Genetics of myeloid malignancies: pathogenetic and clinical implications.

  2005cites this paper
• Oncogenic derivatives of platelet-derived growth factor receptors.

  2004cites this paper
• The GTPase Arf 1 p and the ER to Golgi cargo receptor Erv 14 p cooperate to recruit the golgin Rud 3 p to the cis-Golgi

  2004cites this paper
• Imatinib Therapy in Clonal Eosinophilic Disorders, Including Systemic Mastocytosis

  2004cites this paper
• HCMOGT-1 is a novel fusion partner to PDGFRB in juvenile myelomonocytic leukemia with t(5;17)(q33;p11.2).

  2004cites this paper
• Imatinib therapy for hypereosinophilic syndrome and eosinophilia-associated myeloproliferative disorders.

  2004cites this paper
• PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma.

  2004cites this paper
• PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma

  2004cites this paper
• Myelodysplastic Syndromes

  2004cites this paper
• Oncogenic protein tyrosine kinases

  2004cites this paper
• The GTPase Arf1p and the ER to Golgi cargo receptor Erv14p cooperate to recruit the golgin Rud3p to the cis-Golgi

  2004cites this paper
• Molecular therapeutic approaches to acute myeloid leukemia: targeting aberrant chromatin dynamics and signal transduction

  2004cites this paper
• Breakpoint differentiation in chromosomal aberrations of hematological malignancies: Identification of 33 previously unrecorded breakpoints.

  2004cites this paper